Sprint Bioscience (Sweden) Profile

SEK 0.1  0.4%
23.1Last Month High 25.3 
24.5Trading Day  High 24.9 

Sprint Bioscience Summary

Sprint Bioscience AB (SPRINT) is traded on Stockholm Stock Exchange in Sweden. It is located in H?lsov?gen , th floorHuddinge, and employs 11 people. The company currently falls under 'Small-Cap' category with current market capitalization of 184.07 M. Sprint Bioscience AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 7.57 M outstanding shares. SPRINT BIOSC has accumulated about 6.62 M in cash with 5.7 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.95.
Check Sprint Bioscience Probability Of Bankruptcy

Sprint Bioscience AB Risk Profiles

Key Fundamentals

Sprint Bioscience Against Markets

Current Ratings  

Sprint Bioscience 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 48% 
Sprint Bioscience AB develops pharmaceutical solutions in the areas of cancer and metabolism. more
NameSprint Bioscience AB
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock Stocks Directory
Business AddressH?lsov?gen , th floorHuddinge,
ExchangeStockholm Stock Exchange
IndustryPharmaceuticals And Biosciences
Contact Number46 84 11 44 55
CurrencySEK - Swedish Kronor


Sprint Bioscience Corporate Directors
Jessica Martinsson Director Medicinal Chemistry, Director
Karin Meyer Director
AnneMarie Wenthzel Director of Sales and Marketing


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas